| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |